Zobrazeno 1 - 10
of 258
pro vyhledávání: '"TUMOR DOUBLING TIME"'
Autor:
Herjan J. T. Coelingh Bennink, Iman J. Schultz, Marcus Schmidt, V. Craig Jordan, Paula Briggs, Jan F. M. Egberts, Kristina Gemzell-Danielsson, Ludwig Kiesel, Kirsten Kluivers, Jan Krijgh, Tommaso Simoncini, Frank Z. Stanczyk, Robert D. Langer
Publikováno v:
Breast Cancer Research, Vol 25, Iss 1, Pp 1-16 (2023)
Abstract Many factors, including reproductive hormones, have been linked to a woman’s risk of developing breast cancer (BC). We reviewed the literature regarding the relationship between ovulatory menstrual cycles (MCs) and BC risk. Physiological v
Externí odkaz:
https://doaj.org/article/29597ca8e60744538de2e4f76d9a93a7
Publikováno v:
Cancer Cell International, Vol 21, Iss 1, Pp 1-15 (2021)
Abstract Background Hepatocellular carcinoma (HCC) has become a global health issue of wide concern due to its high prevalence and poor therapeutic efficacy. Both tumor doubling time (TDT) and immune status are closely related to the prognosis of HCC
Externí odkaz:
https://doaj.org/article/a3fa6e037c6447de949456c3a0c1e555
Publikováno v:
Cancer Medicine, Vol 10, Iss 15, Pp 5203-5217 (2021)
Abstract Over the past century, epidemiologic changes and implementation of screening may have had an impact on tumor doubling time in breast cancer. Our study was designed to evaluate changes in tumor doubling time in breast cancer over the past 80
Externí odkaz:
https://doaj.org/article/8e7ecb30500244b7a3cb25306ee248b9
Publikováno v:
Thoracic Cancer, Vol 11, Iss 9, Pp 2600-2609 (2020)
Abstract Background Because shape or irregularity along the tumor perimeter can result from interactions between the tumor and the surrounding parenchyma, there could be a difference in tumor growth rate according to tumor margin or shape. However, n
Externí odkaz:
https://doaj.org/article/ee48b07bfb4d4f34b83acc5d0a1e7934
Autor:
Hiroyuki Hakoda, Yasuharu Sekine, Hideo Ichimura, Kazumitsu Ueda, Shigeo Aoki, Hideyuki Mishima, Akihiro Sako, Keisuke Kobayashi, Akiko Sakata, Yukio Sato
Publikováno v:
Surgical Case Reports, Vol 5, Iss 1, Pp 1-5 (2019)
Abstract Background Patients with liver metastasis from non-small lung cancer (NSCLC) usually have multiple metastases at other sites and thus rarely undergo liver surgery. We present a case involving successful resection of rapidly growing liver met
Externí odkaz:
https://doaj.org/article/6a7af095c18a4a458b2ec7165be0ae38
Autor:
Kentaro Miura, Kazutoshi Hamanaka, Tomonobu Koizumi, Satoshi Kawakami, Nobutaka Kobayashi, Ken-ichi Ito
Publikováno v:
Journal of Cardiothoracic Surgery, Vol 14, Iss 1, Pp 1-10 (2019)
Abstract Background Recently, several reports investigating tumor doubling times (TDTs) in lung cancer have demonstrated that lung cancer patients with shorter TDTs have poor prognoses. Although data have shown that the solid component of a tumor is
Externí odkaz:
https://doaj.org/article/be1f75d86d4b44dbae3854cab333c088
Autor:
Takashi Yamamichi, Masayuki Nakao, Kenshiro Omura, Kohei Hashimoto, Junji Ichinose, Yosuke Matsuura, Yoshinao Sato, Katsunori Oikado, Sakae Okumura, Mingyon Mun
Publikováno v:
Cancer Treatment and Research Communications, Vol 29, Iss , Pp 100446- (2021)
Objective: The coexistence of interstitial lung disease (ILD) is associated with poor prognosis in patients with lung cancer. The tumor doubling time (TDT) of lung cancer reflects cancer aggressiveness and is related to its prognosis. However, the re
Externí odkaz:
https://doaj.org/article/cc0ef79104a64877b8947c981383cc17
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Symmetry, Vol 13, Iss 10, p 1760 (2021)
Chlorambucil (Chl), Melphalan (Mel), and Cytarabine (Cyt) are recognized drugs used in the chemotherapy of patients with advanced Chronic Lymphocytic Leukemia (CLL). The optimal treatment schedule and timing of Chl, Mel, and Cyt administration remain
Externí odkaz:
https://doaj.org/article/d1687a2394c340beb5c27cde8085c101
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.